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Abstract 
Purpose: To investigate a computational approach for analysing the structure-function relationship of 
poliovirus 2A protease using various bioinformatics tools.  
Methods: The three-dimensional structure of 2Apro was modelled and analyzed using the crystal 
structure of coxsakievirus B4 as a template to understand the function of this protein. Structural 
validation programs, VADAR and QMEAN, were used to verify the 2Apro model. Analysis of protein 
stability changes in poliovirus 2A protease-mutated sequences using various servers was also 
performed.  Furthermore, mutation pattern, intrinsic disorder regions (IDRs), hydrophobic regions, drug 
binding sites (DBS) and subcellular localization were identified.  
Results: Hydrophobicity results confirmed the suitability and reliability of 2A protease as a potential 
drug target. Less IDRs were observed in the protein. Moreover, the results showed the presence of 
various important drug binding targets among conserved regions of the protease. The predicted drug 
binding sites indicate their suitability for the inhibition and development of anti-viral drugs against 
poliovirus 2A protease.  
Conclusion: The current study resulted in the detection of important ligand interactions with respect to 
the binding site of the targeted protein. Thus, these compounds may be potent drug candidates and 
their potency may be increased against poliovirus 2A protease with relatively simple structural changes. 
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 Viral proteins involved in the cellular functions 
and manipulation of cellular processes by viruses 
have gained significant attention from the 
pharmaceutical and biotechnology industries as 
a potential source of drug targets [1]. Poliovirus 
proteinases are excellent substrates for drug 
development due to their key roles in the 
replication cycle. 
 
Drug targets are proteins or protein products 
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including G-protein coupled receptors, enzymes, 
ion channels and amino acids. To accomplish 
desirable therapeutic effects drugs tend to bind 
to their matching targets [2]. The extreme genetic 
variability and high mutation rate of RNA viruses 
such as poliovirus makes the design of antiviral 
drugs complicated. Polioviruses are therefore 
termed “quasi-species” [3-5]. 
 
Poliovirus (PV) of the Picornaviridae, has been 
categorized into three stable subtypes (1, 2 and 
3). The PV genome comprises +ss RNA of 
approximately 7,440 nucleotides. The genome is 
packaged in a non-enveloped icosahedral protein 
capsid [6]. PV replication is carried out through a 
single open reading frame termed a polyprotein. 
Two cysteine proteases (2A and 3C) are involved 
in proteolytic processing of polyprotein, which are 
crucial for viral life cycle [7]. The poliomyelitis 
epidemic resulted in the discovery of two 
important vaccines, OPV and IPV. No drug is 
available for treating poliomyelitis. 
 
PV 2Apro plays a leading role in autocatalytic 
cleavage process of poliovirus polyprotein. 2Apro 
is involved in cleavage of eIF4G (eukaryotic 
translation initiation factor 4G [8]. Studies have 
demonstrated the role of poliovirus 2Apro in 
activating the apoptotic process in PV-infected 
cells, and it also exhibits anti-apoptotic activity 
[9]. 
 
The poliovirus 2Apro crystal structure is unknown; 
however, it is possibly very close to the known 
structure of HRV2 2Apro [10]. Research on 2Apro 
inhibitors has been limited so far. However, a 
number of peptide-based inhibitors have been 
developed against 2Apro. Anti-2A inhibitors are 
expected to show the additional advantage of 
suppressing genetic reversion along with 
negative effect son capsid formation [11]. 
Poliovirus proteases display minimal similarity to 
known mammalian enzymes, making them 
excellent drug targets [12]. The aim of this study 
was to explore poliovirus 2A protease as a 
probable drug target through computational 
approaches. Sequences in which mutations were 
already reported were used [13]. Analysis was 
performed to investigate drug target sites of 
2Apro. We also investigated the effect of 
mutations on protein stability. The degree of 
conservation was mapped on the 3D structure of 
the proteins and compared with the novel 
predicted intrinsic disordered regions (IDRs) of 





Figure 1: Schematic representation of prioritization pipeline in identifying regions with more DBS and least IDS 
based on various in-silico tools 







The 2A protease was amplified from blood 
samples (001 and 002) (from polio patients in the 
KP district of Pakistan with the help of Frontier 
Development Organization) then cloned into a 
TA cloning vector (PCR 2.1) and sent for 
sequencing (Eurofin, USA). The sequences were 
analyzed and submitted to Genbank (KF193869 
and KF193870 for 001 and 002 respectively) 
[13]. Total of four mutations in the poliovirus 2A 
protease were observed after sequencing. 
Alanine residue (at position 12) was mutated into 
glycine, while wild type aspartic acid residue at 
position 36  was mutated into asparagine and 
normal serine was mutated to threonine at 
position 134 and isoleucine mutated to valine at 
amino acid position 136.  
 
Homology modelling and model reputation 
 
A PDB file of 001 and 002 samples of 2A 
protease was generated by the Swiss-Model 
server [14]. The structure of coxsackievirus B4 
(1z8r) model was selected as a template to 
obtain the 2A model. The backbone conformation 
of the modelled structure of 001 and 002 
proteases was calculated by investigating the 
torsion angles via Ramachandran plot version 
2.0 [15]. Further analysis of the predicted model 
was done by QMEAN [16] and ProSA [17]. 
VADAR was performed to determine the volume 
area dihedral angle for fractional accessible 
surface area [18]. 
 
Protein structure prediction 
 
I-Tasser [19] server was used to predict protein 
structure by giving precise structural and 
functional predictions by means of algorithms 
[20]. A total of five models were obtained based 
on the five largest structure clusters. Confidence 
scores (C-score) were calculated based on the 
significance of threading template alignments. C-
scores lied in the range of [-5, 2], where a higher 
value indicates a model with a high confidence 
and vice-versa.  A TM-score (template modelling 
score) of > 0.5 predicts a model of correct 
topology while a TM-score < 0.17 specifies a 
random similarity. 2Apro sequences containing 
mutations were subjected to structure prediction 
by I-Tasser. 
 
Protein stability prediction 
 
I-Mutant 2.0 [21] network predicts protein stability 
changes upon single point mutation from protein 
sequence/structure [22]. Output is obtained in the 
form of protein stability change and Gibbs-free 
energy change (DDG) using Eq 1. 
 
DDG = DG (mutant Protein) - DG (wild-type, kcal/mol) ..… (1) 
 
Furthermore, STRUM was used to predict fold 
stability change (ΔΔG) of protein molecules upon 
single-point mutations [23].  
 
EASE-MM sequence-based prediction of 
mutation-induced stability changes [24], was also 
used to affirm the stability of the protein upon 
mutations. Results are displayed in the form of 
an increase or decrease in stability upon 
mutation induction. 
 
Protein intrinsic disorder region (IDR) 
analysis 
 
Variations in IDR structural properties can play a 
regulatory role in protein activity. The IDRs of the 
001 and 002 poliovirus 2A protease, were 
estimated using four software packages: 
MetaPrDOS [25], DisEMBL [26], PSIPRED [27] 
and IUPred [28]. A disorder score (0-1) for each 
amino acid position was calculated. Position of 
an amino acid was considered IDR if its disorder 
score was observed above the cut-off value of 
0.5. 
 
Prediction of hydrophobicity 
 
Prediction of overall hydrophobic residues of 001 
and 002 poliovirus 2A protease was performed 
using the TM Finder tool [29]. The TM-Finder 
predicts trans-membrane proteins. The regions 
are predicted to be trans-membrane based on 
the hydrophobicity and helicity of the adjacent 
amino acid sequences. The threshold value for 
hydrophobicity is 0.4 and values exceeding the 
threshold level predict the transmembrane nature 
of the protein [29]. Hydrophobicity results of the 
protein were also confirmed using the 
PEPTIDE.2 server. 
 
Prediction protein–ligand-drug binding site  
 
Tertiary structures of 001 and 002 poliovirus 2A 
protease were analyzed to predict the number of 
drug binding sites. The online servers COACH 
[19, 30] I-Tasser were used to determine the 
number of binding sites and their positions. 
COACH is a meta-server approach for the 
prediction for ligand binding targets through two 
comparative methods TM-SITE [31] and S-SITE. 
The BioLiP protein function database is used in 
these methods to recognize ligand binding sites. 
These predictions were later combined with the 
results obtained from other methods including 
ConCavity [32], FINDSITE [33] and COFACTOR 
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[20]. To predict the final ligand binding site of the 
protein, PDB structures of 001 and 002 poliovirus 
2A protease were given to the server for 
analysis. Complete results were given in the form 
of the position of the potential drug binding site. 
 
Subcellular localization analysis 
 
To understand a protein’s function and its 
suitability as a vaccine/target, subcellular 
localization analysis is performed. Cytoplasmic 
proteins tend to have more potential as drug 
targets compared to surface membrane proteins 
[34]. The CELLO v.2.5 [35] server was employed 
to predict subcellular localization of poliovirus 2A 
protease. The results were further validated with 
predictions obtained from Virus-mPLoc [36], 




Structures of 001 and 002 PV2A protease 
models 
 
The Swiss-Model predicts the 3D structure of 
both the models on the basis of known crystal 
structure of the protein (Figure 2). The maximum 
scoring and validated model for PV2A protease 
exhibiting the highest sequence identity with the 
crystal structure was coxsackievirus B4 (PDB ID: 
1Z8R.A). 
 
The stereo-chemical attributes of the predicted 
protein models were investigated through 
QMEAN (Table 1) and evaluated by 
Ramachandran plots (Figure 3). 
 
The QMEAN4 and QMEAN6 score [39] of the 
model was close to the value of 0, showing the 
reliability of the model (model reliability in 
between 0 and 1; Table 1). Predicted structure 
analysis delivered solid evidence of the good 
quality of predicted 3D structure of poliovirus 2A 
protease. 
 
Protein model quality and accessible surface 
area (ASA) was predicted through VADAR. 
Accessible surface area to water molecules was 
measured as fractional ASA range (0 to 1). 
Results of ASA showed that the major portion of 
the protein is hydrophobic, having ASA scores 
less than 0.8 signifying tight folding of the protein 
(Figure 4). 
 
Predicted drug binding sites (DBS) 
 
DBS analysis predicted functional ligand binding 
sites. All of these binding site residues of both 
models were also confirmed when predicted 
through different methods including COFACTOR, 
FINDSITE, TM-SITE and ConCavity. In the case 
of COFACTOR His 4, Gln 5, Asn 6, Lys 7, Ala 8, 
His 20, Leu 21, Asp 38, Cys 55, Cys 57, Gln 81, 
Tyr 82, Met 83, Glu 84, Asn 86, Tyr 88, Tyr 89, 
Arg 92, Gln 94, Asp 108, Cys 115, His 117, Ile 
123, Thr 124, Ala 125,  Gly 126, Gly 127, Leu 
130 and Ala 132 were predicted as potential 
binding sites for 001 and 002 (Figure 5A and 5B). 
In contrast, FINDSITE predicted Phe 2, Gly 3, 
His 4, Gln 5, Asn 6, Lys 7, His 20, Leu 21, Ala 
22, Thr 24, Glu 25, Asp 26, Leu 27, Ser 29, Val 
30, Asn 31, Val 33, Asp 38, Val 41, Thr 42, Arg 
45, Gln 47, Ser 51, Lys 69, Tyr 83, Asn 86, Tyr 
89, Ala 91, Arg 92, Gly 107, Asp 108, Cys 109, 
Ile 123,  Thr 124, Ala 125, Gly 126, Gly 127, Gly 
129, Val 131 and Phe 133 as potential binding 
sites (Figure 5C and 5D). 
 
His 20, Leu 21, Asp 38, Cys 55, Cys 57, Met 83, 
Glu 84, Arg 92, Gln 94, Asp 108, Cys 115, His 
117, Ile 123, Thr 124, Ala 125 and Gly 126 were 
predicted as potential drug binding sites of 001 
and 002 according to TM-SITE results (Figure 6A 
and 6B), while ConCavity results predicted Gln 5, 
Asn 6, Lys 7, Ala 8, Asn 18, Tyr 19, His 20, Leu 
21, Asp 38, Asp 50, Tyr 62, Tyr 71, Tyr 83, Asn 
87, Tyr 88, Tyr 89, Gln 94, Gly 100, Gly 102, Phe 
103, Ala 104, Pro 106, Gly 107, Cys 109, Gly 
110, Ile 112, Arg 114,  Ile 123,  Thr 124, Gly 126, 
Gly 129 and Val 131 as potential drug binding 
residues (Figure 6C and 6D). 
 
Intrinsic disorder region prediction 
 
To understand protein folding and function, 
precise prediction of a protein's tendency to have 
intrinsic disordered regions is an essential step. 
The current investigation used four software 
packages to identify disordered positions based 
on the majority voting by these software tools. In 
this prediction server, a residue is considered as 
disordered if its score is above 0.5. Based on the 
real valued disorder propensities generated by 
MetaPrDOS [25], DisEMBL [26], PSIPRED [27] 
and IUPred [28] analysis, disordered regions are 
defined as regions with scores above the 
threshold line (0.5); however, scores below this 
line specify a degree of flexibility. In the case of 
001 and 002, regions GFGH (1-4) and EAMEQ 




Subcellular localization prediction of PV2A 
protease specifies its localization in the 
cytoplasmic membrane with no signal peptide 
and transmembrane helix. 
 




Figure 2: 3D model generation through Swiss model software. A and B indicate the model produced for 




Figure 3: Ramachandran plot analysis of 001 (A) and 002 (B) protein. Red colour indicates core region, yellow 
indicates allowed region, green is allowed region, grey is disallowed region 
 
Table 1: QMEAN global scores for 001 002, and template models obtained from Swiss modelling 
 
Scoring function term 
Z-score 





QMEAN6 score -4.16 -3.55 -4.18 
QMEAN4 score -4.12 -3.41 -3.92 
All-atom pairwise energy -2.23 -2.28 -2.48 
C_beta interaction energy -0.71 -0.84 -1.43 
Solvation energy -1.51 -1.56 -1.91 
Torsion angle energy -3.57 -2.82 -3.17 
SS Agreement -1.38 -1.04 -1.34 
ACC Agreement -0.91 -1.24 -1.31 
 




Figure 4: Accessible surface area (ASA) prediction of 001 (A) and 002 (B) protease models using VADAR server 
 





Figure 5: Ligand binding sites prediction through COACH server. A and B are the predictions from COFACTOR 
of 001 and 002 respectively, while C and D are the results of FINDSITE methods. Ligand binding sites are shown 




Figure 6: Ligand binding sites prediction through COACH server. A and B are the predictions from TM-SITE of 
001 and 002 respectively while C and D are the results of ConCavity. Ligand binding sites are shown in purple 
colour 
 
Protein stability with mutations 
 
The protein stability change upon mutation was 
assessed by using I-Mutant 2.0, STRUM and 
EASE-MM web-servers. The results showed the 
effect of mutants on stability of protein with 
reliability index at pH 7.0 and temperature 25 °C. 
Mutations (A12G, D36N, S134T, I136V) used in 





Hydrophobic interactions play an important role 
in drug design involving biophysical events for 
instance protein-ligand or protein-protein binding. 
Hydrophobic regions of the selected 001 and 002 
proteins were determined with PEPTIDE 2 and 
TM-Finder. These software predicted the 
calculated hydrophobicity and helicity values, 
along with the predicted TM-segments of the 
proteins (Figure 8). In case of both proteins most 
residues were found to be hydrophobic (34.9 %) 




Poliovirus 2A protease is involved in many 
physiological processes, making it an important 
target in the cysteine protease superfamily of 
proteins. However, the absence of a high 
resolution crystal structure of poliovirus 2A 
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protease is a limitation in understanding atomic 
details [10]. In this study, we took advantage of 
the PV2Apro primary structural similarity to other 
viral proteases, specifically that from 
Coxsackievirus B4, and performed an in silico 
analysis of its structure. Poliovirus 2A protease 
sequences (001 and 002) were taken from our 
previous work where we have reported the 
mutations in this protein. 
 
No previous studies have reported mutations 
detected in the poliovirus 2A protease. In this 
study, we performed a computational analysis on 
these mutations to determine their impact on 
protease structure, function and stability. Intrinsic 
disordered region prediction results proved it to 
be suitable for drug binding sites, with a low 
number of residues lying in the disordered 
regions. Moreover, hydrophobicity results 
predicted that these proteases have more 
hydrophobic residues compared to hydrophilic 
residues. Important drug binding sites were 
predicted using the COACH server for these 
mutation containing proteases. These important 
residues include His20, Leu21, Asp38, Cys55, 
Cys57, Met83, Tyr88, Tyr89, Asp108, Cys109, 
Cyss115, His117, Ile123, Thr124, Ala125 and 
Gly126.  
Previous studies have reported that His20, 
Cys109, Cys55, Cys57, Cys115 and His117 are 
involved in structural maintenance and catalytic 
activity of 2Apro [40]. Proteinase 2A of human 
rhinovirus 2 (HRV2 2A) Cys residues and His114 
are important residues involved in coordinating 
Zn+2. Moreover, Gly123, Gly124, Thr121 and 
Cys101 are suggested to form part of the 
construction of the substrate binding pocket and 
to offer a suitable setting for the active site of 
His18, Asp35 and Cys106 [41].   
 
Previously reported mutations (A12G, D36N, 
S134T, I136V) in poliovirus 2A protease were 
subjected to predict single nucleotide 
polymorphisms along with their impact on 
protease stability. All mutations result in a 
decrease of protein stability, thus destabilizing 
the protein structure. Defects in cis cleavage with 
the minute plaque phenotype have been 
observed in poliovirus point mutants (G60R, 
S66F, L39F, N18K, D135N, V119M, A22T, 
C55Y, and S134L) when the poliovirus 2A gene 
was expressed in yeast [42].  Previously it was 
reported that single amino acid mutations at the 
His20 and Cysl09 residues led to complete loss 





Figure 7: Intrinsic disorder regions of 001 (A) and 002 (B). Scores above the grey line are the disorder region, 
whereas scores below the grey line show degree of flexibility 
 





Figure 8: Hydrophobicity results of 001 (A) and 002 (B) model. Red amino acids are amino acids in a TM 
segment and Blue amino acids are charged amino acids in the TM segment 
 
Important ligand-protein interactions have been 
identified following docking investigations in this 
study, providing potential candidates for drug 
targeting, the potency of which may be increased 




A structure-function investigation of the poliovirus 
2A protease is presented in the study. By using 
the crystal structure of coxsackievirus B4 as a 
template, the three-dimensional structure of the 
poliovirus 2A protease was predicted. I-TASSER 
and COACH results identified potential binding 
sites in the protein structure. Use of 
computational approaches to identify more 
potential drug binding sites in the conserved 
regions will lead to better drug design methods in 
the years ahead. This computational approach 
may be combined with experimental methods, 
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